Biotechnology

New patent expiration for the drug Novartis PROMACTA – DrugPatentWatch

[ad_1]

Copyright © DrugPatentWatch. Originally published in Recently expired patent for the drug Novartis PROMACTA

Annual Drug Patent Expiration for PROMACTA
Annual Drug Patent Expiration for PROMACTA

Promacta is a drug marketed by Novartis and is included in two NDAs. It is available from a single supplier. There are eight patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in PROMACTA is eltrombopag olamine. One registered supplier for this compound. Additional details are available on eltrombopag olamine’s profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published in Recently expired patent for the drug Novartis PROMACTA

[ad_2]

Source link

Related Articles

Back to top button